MCID: MYF002
MIFTS: 39

Myofascial Pain Syndrome

Categories: Muscle diseases

Aliases & Classifications for Myofascial Pain Syndrome

MalaCards integrated aliases for Myofascial Pain Syndrome:

Name: Myofascial Pain Syndrome 12 15 17
Myofascial Pain Syndromes 44 72
Myofascial Pain Dysfunction Syndrome 55
Fibromyalgia 72

Classifications:



External Ids:

Disease Ontology 12 DOID:431
MeSH 44 D009209
UMLS 72 C0016053 C0027073

Summaries for Myofascial Pain Syndrome

MalaCards based summary : Myofascial Pain Syndrome, also known as myofascial pain syndromes, is related to fibromyalgia and chronic pain, and has symptoms including muscle weakness, fatigue and myoclonus. An important gene associated with Myofascial Pain Syndrome is POMC (Proopiomelanocortin). The drugs Etoricoxib and Dinoprostone have been mentioned in the context of this disorder. Affiliated tissues include brain, breast and testes.

Wikipedia : 75 Myofascial pain syndrome (MPS), also known as chronic myofascial pain (CMP), is a syndrome characterized... more...

Related Diseases for Myofascial Pain Syndrome

Diseases related to Myofascial Pain Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 82)
# Related Disease Score Top Affiliating Genes
1 fibromyalgia 12.1
2 chronic pain 10.6
3 trichorhinophalangeal syndrome 10.5
4 paine syndrome 10.4
5 chronic fatigue syndrome 10.4
6 bruxism 10.4
7 rheumatic disease 10.2
8 autonomic dysfunction 10.2
9 back pain 10.2
10 headache 10.2
11 frozen shoulder 10.2
12 enthesopathy 10.2
13 bursitis 10.2
14 radiculopathy 10.2
15 spasticity 10.2
16 glossopharyngeal neuralgia 10.2
17 temporomandibular joint anomaly 10.2
18 carpal tunnel syndrome 10.1
19 reflex sympathetic dystrophy 10.1
20 anxiety 10.1
21 lyme disease 10.1
22 algoneurodystrophy 10.1
23 mental depression 10.1
24 thoracic outlet syndrome 10.1
25 neuropathy 10.1
26 fasciitis 10.1
27 irritable bowel syndrome 10.1
28 48,xyyy 10.1
29 piriformis syndrome 10.1
30 depression 10.1
31 mucolipidosis iii alpha/beta 10.0
32 mucolipidosis iii gamma 10.0
33 branchiootic syndrome 1 10.0
34 mucolipidosis 10.0
35 pulpitis 10.0
36 guillain-barre syndrome 10.0
37 facial neuralgia 10.0
38 cranial neuralgia 10.0
39 neurodermatitis 10.0 TAC1 POMC
40 epicondylitis 9.9 TAC1 NDUFB8
41 pfeiffer syndrome 9.9
42 amyotrophic lateral sclerosis 1 9.9
43 spondyloarthropathy 1 9.9
44 fibrosis of extraocular muscles, congenital, 1 9.9
45 temporal arteritis 9.9
46 trigeminal neuralgia 9.9
47 fibrosclerosis, multifocal 9.9
48 multiple pterygium syndrome, lethal type 9.9
49 pulmonary alveolar microlithiasis 9.9
50 body mass index quantitative trait locus 1 9.9

Graphical network of the top 20 diseases related to Myofascial Pain Syndrome:



Diseases related to Myofascial Pain Syndrome

Symptoms & Phenotypes for Myofascial Pain Syndrome

UMLS symptoms related to Myofascial Pain Syndrome:


muscle weakness, fatigue, myoclonus, myalgia, back pain, pain, torticollis, chronic pain, sciatica, muscle cramp, muscle rigidity, muscle spasticity, myofascial trigger point pain

Drugs & Therapeutics for Myofascial Pain Syndrome

Drugs for Myofascial Pain Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 308)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Etoricoxib Approved, Investigational Phase 4 202409-33-4 123619
2
Dinoprostone Approved Phase 4 363-24-6 5280360
3
Colchicine Approved Phase 4 64-86-8 6167 2833
4
Acetaminophen Approved Phase 4 103-90-2 1983
5
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
6
Perphenazine Approved Phase 4 58-39-9 4748
7
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
8
Eszopiclone Approved, Investigational Phase 4 138729-47-2 969472
9
Hydrocortisone acetate Approved, Vet_approved Phase 4 50-03-3
10
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754
11
Paroxetine Approved, Investigational Phase 4 61869-08-7 43815
12
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
13
Granisetron Approved, Investigational Phase 4 109889-09-0 3510
14
Trazodone Approved, Investigational Phase 4 19794-93-5 5533
15
Histamine Approved, Investigational Phase 4 51-45-6 774
16
Flunarizine Approved Phase 4 52468-60-7 941361
17
Sodium citrate Approved, Investigational Phase 4 68-04-2
18
Triamcinolone Approved, Vet_approved Phase 4 124-94-7 31307
19
Sodium oxybate Approved Phase 4 502-85-2 5360545
20
tannic acid Approved Phase 4 1401-55-4
21
Benzocaine Approved, Investigational Phase 4 94-09-7, 1994-09-7 2337
22
Promethazine Approved, Investigational Phase 4 60-87-7 4927
23
Suvorexant Approved, Investigational Phase 4 1030377-33-3
24
Diphenhydramine Approved, Investigational Phase 4 58-73-1, 147-24-0 3100
25
Naloxone Approved, Vet_approved Phase 4 465-65-6 5284596
26
Buprenorphine Approved, Illicit, Investigational, Vet_approved Phase 4 52485-79-7 40400 644073
27
Glutamic acid Approved, Nutraceutical Phase 4 56-86-0 33032
28
Vitamin D3 Approved, Nutraceutical Phase 4 67-97-0 6221 5280795
29
Ergocalciferol Approved, Nutraceutical Phase 4 50-14-6 5280793
30
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4 1406-16-2
31
Citric acid Approved, Nutraceutical, Vet_approved Phase 4 77-92-9 311
32
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4 22737-96-8, 11103-57-4, 68-26-8 9904001 445354
33 Cyclooxygenase 2 Inhibitors Phase 4
34 Tubulin Modulators Phase 4
35 Antimitotic Agents Phase 4
36 Antirheumatic Agents Phase 4
37 Anti-Inflammatory Agents, Non-Steroidal Phase 4
38 Antipyretics Phase 4
39 Vitamins Phase 4
40 Micronutrients Phase 4
41 Nutrients Phase 4
42 Trace Elements Phase 4
43 Quetiapine Fumarate Phase 4 111974-72-2
44 Antipsychotic Agents Phase 4
45 Antiemetics Phase 4
46 Gastrointestinal Agents Phase 4
47 Autonomic Agents Phase 4
48 Serotonin Antagonists Phase 4
49 Cytochrome P-450 CYP2D6 Inhibitors Phase 4
50 Cytochrome P-450 Enzyme Inhibitors Phase 4

Interventional clinical trials:

(show top 50) (show all 896)
# Name Status NCT ID Phase Drugs
1 An Open-Label Pilot Study to Assess Potential Mechanisms for Fibromyalgia in Peripheral Tissue Innervation That Could Predict Therapeutic Responsiveness to Milnacipran Unknown status NCT01125423 Phase 4 Milnacipran
2 Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? A Randomized, Double-blinded, Placebo-controlled, Crossover Study. Unknown status NCT02806440 Phase 4 Low dose naltrexone;Placebo
3 An Eight Week, Double-Blind Efficacy Study of Cyclobenzaprine ER (Amrix TM) Augmentation to Alleviate Fibromyalgia Fatigue and Muscle Pain Unknown status NCT01041495 Phase 4 cyclobenzaprine ER (AMRIX);placebo
4 Study Proposal - A Randomized Double-blinded Study Comparing Adding Etoricoxib Versus Placebo to Female Patients With Fibromyalgia-analysis of Organic and Psychiatric Measures Unknown status NCT00755521 Phase 4 etoricoxib
5 A Double-Blind, Placebo-Controlled, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis Unknown status NCT01329406 Phase 4 Milnacipran;Placebo
6 The Impact of Perioperative Gabapentin on Chronic Groin Pain After Inguinal Hernia Repair Unknown status NCT02419443 Phase 4 Gabapentin;Placebo
7 The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain Unknown status NCT01417923 Phase 4 vitamin D
8 The Efficacy of Topical Thiocolchicoside in Cervical Myofascial Pain Syndrome: Triple-Arm, Single-Blind, Randomized, Prospective, Phase IV Clinical Study Completed NCT00272532 Phase 4 Thiocolchicoside
9 Treatment of Myofascial Pain Syndrome With Lidocaine Injection and Physical Therapy, Alone or in Combination: a Single-blind, Randomized, Controlled Clinical Trial. Completed NCT01250184 Phase 4 Lidocaine injection
10 A 6-month, Open-label, Safety Trial Of Pregabalin In Adolescent Patients With Fibromyalgia Completed NCT01020526 Phase 4 pregabalin
11 A 15 Week, Randomized, Double Blind, Parallel-group, Placebo-controlled, Flexible-dose, Safety And Efficacy Study Of Pregabalin In Adolescents (12-17 Years Old) With Fibromyalgia Completed NCT01020474 Phase 4 placebo;pregabalin (Lyrica)
12 Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot Study Completed NCT00983320 Phase 4 quetiapine;placebo
13 A Randomized, Double-Blind Comparison of Duloxetine 30 mg QD and Placebo in Adult Patients With Fibromyalgia Completed NCT00965081 Phase 4 Duloxetine;Placebo
14 Open Label Trial Concerning the Effectiveness of Trazodone in the Treatment of Fibromyalgia (Phase I) and Its Augmentation With Pregabalin in Trazodone Partial Responders (Phase II) Completed NCT00791739 Phase 4 trazodone, pregabalin
15 A Randomized, Pilot Clinical Trial to Assess the Comparative Efficacy and Tolerability of Quetiapine XR Versus Amitriptyline for the Treatment of Patients With Fibromyalgia Completed NCT00766350 Phase 4 amitriptyline;quetiapine
16 A Multicenter, Randomized, Double-blind, Placebo-Controlled Discontinuation Study of the Durability of Effect of Milnacipran for the Treatment of Fibromyalgia in Patients Receiving Long-term Milnacipran Treatment Completed NCT01014585 Phase 4 Placebo;Milnacipran
17 Flexible Dosed Duloxetine Versus Placebo in the Treatment of Fibromyalgia Completed NCT00673452 Phase 4 duloxetine hydrochloride;placebo
18 A Randomized Controlled Trial Comparing the Efficay and Tolerability of Ai Chi Versus Stretching in Fibromyalgia Management: a Six Months Study Completed NCT00600574 Phase 4
19 Eszopiclone in the Treatment of Insomnia and Associated Symptoms of Fibromyalgia Completed NCT00392041 Phase 4 Eszopiclone;placebo
20 The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia Completed NCT01234675 Phase 4 Milnacipran;Placebo
21 Quetiapine Compared With Placebo in the Management of Fibromyalgia Completed NCT01458964 Phase 4 Quetiapine
22 Pool-based Exercise in Fibromyalgia Management: a Prospective Randomized Comparison Between Stretching and Ai Chi Completed NCT00550641 Phase 4
23 Fixed Versus Flexible Dosing of Pregabalin in Patients With Fibromyalgia Completed NCT01226667 Phase 4 Pregabalin
24 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Switch Study to Evaluate the Safety, Tolerability and Efficacy of Milnacipran in Patients With an Inadequate Response to Duloxetine for the Treatment of Fibromyalgia Completed NCT01077375 Phase 4 Placebo;Milnacipran
25 Effectiveness of Strengthening Exercises Using the Swiss Ball for Patients With Fibromyalgia: a Randomized Controlled Trial Completed NCT02063750 Phase 4
26 Ultracet (Tramadol HCL [37.5 mg]/Acetaminophen [325 mg]) Combination Tablets in the Treatment of the Pain of Fibromyalgia Completed NCT00766675 Phase 4 Tramadol hydrochloride;Acetaminophen
27 Probe Study to Evaluate the Efficacy of Botulinum Toxin Serotype A Injections for Cervicobrachial Myofascial Syndrome Completed NCT00241215 Phase 4 Botulinum toxin serotype A
28 Effects of a 12 Week Milnacipran 200 mg Treatment on Pain Perception and Pain Processing in Fibromyalgia - An Open Label Study Completed NCT01288807 Phase 4 Milnacipram
29 A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and Tolerability of Quetiapine Fumarate Sustained Release(Seroquel SRTM) in the Treatment of Major Depression With Comorbid Fibromyalgia Syndrome. Completed NCT00675896 Phase 4 Quetiapine Fumarate Sustained Release;Placebo
30 Perception of Discomfort and Psychosocial Difficulties in People With Diagnosis of Fibromyalgia and Predominant Neck Pain Completed NCT02078791 Phase 4 Botox infiltration
31 A Randomized, Double-blind,Placebo-controlled, Two-way Crossover Study to Evaluate the Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging Activation Patterns in Patients With Fibromyalgia Completed NCT01173055 Phase 4 milnacipran;Placebo
32 An Eight Week, Double-Blind Efficacy Study of Armodafinil Augmentation to Alleviate Fibromyalgia Fatigue Completed NCT00678691 Phase 4 armodafinil;placebo
33 A Pilot Study on the Combined Use of Cognitive Behavioral Therapy (CBT) and Milnacipran Completed NCT01038323 Phase 4 Educational with milnacipran
34 A Pilot Study on the Use of Nociceptive Flexion Reflex for Fibromyalgia Completed NCT00965601 Phase 4
35 Combining N-of-1 Trials to Assess Fibromyalgia Therapies Completed NCT00000428 Phase 4 Amitriptyline;Amitriptyline plus Fluoxitine
36 The Study of Heart Rate Variability in Patients With Fibromyalgia - Effects of Strengthening Exercises Completed NCT02004405 Phase 4
37 Paroxetine-CR (Paxil-CR) in the Treatment of Patients With Fibromyalgia Syndrome: A Randomized, Double Blind, Parallel Group, Flexible Dose, Placebo Controlled Trial. Completed NCT00610610 Phase 4 Paroxetine CR;Placebo
38 Randomized, Double-blind, Placebo-controlled Trial to Measure the Efficacy and Safety of Vitamin D3 in Patients With Fibromyalgia. Completed NCT03369379 Phase 4 D3 Vitamin
39 MuscleCare™ Pain Relief Therapy vs. Voltaren® in the Relief of Trapezius Trigger Point Musculoskeletal Pain. Completed NCT03939884 Phase 4 MuscleCare Topical Product;Voltaren Topical;Nivea, Topical Cream
40 The Serotonin Receptor Type 3 Antagonist Granisetron as a New Treatment Approach for Patients With Chronic Myofascial Pain in the Orofacial Muscles Completed NCT02230371 Phase 4 Granisetron;Control (placebo)
41 A Randomized, Single-dose, Parallel-group Study to Evaluate the Pharmacokinetic Profiles of Two Formulation of Pregabalin in Healthy Volunteers Under Fasting Conditions Completed NCT03712475 Phase 4 Pregabalin
42 Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17, Demonstration of Double-blind Trial Results Completed NCT03558971 Phase 4 Cortisol
43 Use of Lisdexamfetamine Dimesylate in Treatment of Cognitive Impairment (Chronic Fatigue Syndrome): A Double Blind, Placebo Controlled Study Completed NCT01071044 Phase 4 Lisdexamfetamine Dimesylate;Placebo "30, 50 or 70 mg"
44 Milnacipran in the Treatment of Widespread, Non-Joint Pain in Rheumatoid Arthritis Completed NCT01207453 Phase 4 Milnacipran;Placebo
45 Efficacy of Pregabalin in Patients With Radicular Pain Completed NCT00908375 Phase 4 Pregabalin;Sugar Pill
46 An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome Without Comorbid Major Depressive Disorder Completed NCT00401258 Phase 4 duloxetine
47 Randomized Double-blind Study Comparing the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular Component Completed NCT01166048 Phase 4 Duloxetine;Duloxetine
48 An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder Completed NCT00961298 Phase 4 Duloxetine
49 Milnacipran for the Pain, Sensory Sensitization and Mood Changes in Knee Osteoarthritis Completed NCT01510457 Phase 4 Milnacipran;Placebo
50 Neurologic Signatures of Chronic Pain Disorders Recruiting NCT02747940 Phase 4 flunarizine and/or pregabalin

Search NIH Clinical Center for Myofascial Pain Syndrome

Inferred drug relations via UMLS 72 / NDF-RT 51 :


(+)-menthol
(S)-camphor
2-(l-menthoxy)ethanol
Baclofen
Camphor
Chondroitin sulfate
DL-Methylephedrine
Methocarbamol
Methyl nicotinate
Nortriptyline
St. John's Wort
Trolamine
Turpentine

Cochrane evidence based reviews: myofascial pain syndromes

Genetic Tests for Myofascial Pain Syndrome

Anatomical Context for Myofascial Pain Syndrome

MalaCards organs/tissues related to Myofascial Pain Syndrome:

41
Brain, Breast, Testes, Cortex, Heart, Spinal Cord, Skeletal Muscle

Publications for Myofascial Pain Syndrome

Articles related to Myofascial Pain Syndrome:

(show top 50) (show all 714)
# Title Authors PMID Year
1
Ultrasound guided erector spinae plane block for myofascial pain syndrome. 38
30995595 2019
2
Myofascial pain syndrome and trigger points: evaluation and treatment in patients with musculoskeletal pain. 38
31313700 2019
3
Interventions for myofascial pain syndrome in cancer pain: recent advances: why, when, where and how. 38
31348012 2019
4
Feasibility of a Support Vector Machine Classifier for Myofascial Pain Syndrome: Diagnostic Case-Control Study. 38
30614553 2019
5
Piriformis Syndrome: A Narrative Review of the Anatomy, Diagnosis, and Treatment. 38
31102324 2019
6
Rhomboid intercostal block for myofascial pain syndrome in a patient with amyotrophic lateral sclerosis. 38
31334619 2019
7
Comparison of the Efficacies of Dry Needling and Botox Methods in the Treatment of Myofascial Pain Syndrome Affecting the Temporomandibular Joint. 38
31299766 2019
8
Factors Associated With Nonadherence to Pelvic Floor Physical Therapy Referral for the Treatment of Pelvic Pain in Women. 38
30916754 2019
9
Performance of the revised 2016 fibromyalgia diagnostic criteria in Korean patients with fibromyalgia. 38
31342642 2019
10
Effect of transcutaneous electrical acupuncture point stimulation on expression of p-JNK in the dorsal root ganglion in a rat model of myofascial pain syndrome. 38
31219313 2019
11
Early results of supervised versus unsupervised rehabilitation of patients with cervical pain. 38
31177899 2019
12
Thermographic evaluation of occlusal splint and low level laser therapy in myofascial pain syndrome. 38
31126567 2019
13
[Correlation analysis between the surface electromyography and muscle fiber types of the core muscle group in the patients with myofascial pain syndromes]. 38
31277539 2019
14
Chronic and Complex Myofascial Pain Syndromes in Chronic Abdominal Wall Pain. 38
31054611 2019
15
In Reply: Chronic and Complex Myofascial Pain Syndromes in Chronic Abdominal Wall Pain. 38
31054612 2019
16
Evidence for kinesio taping in management of myofascial pain syndrome: a systematic review and meta-analysis. 38
30712369 2019
17
Pharyngeal airway dimension in patients before and after treatment of myofascial pain syndrome. 38
31007142 2019
18
Assessment of predisposing factors in myofascial pain syndrome and the analgesic effect of trigger point injections - A primary therapeutic interventional clinical trial. 38
31000895 2019
19
Effectiveness of hot herbal compress versus topical diclofenac in treating patients with myofascial pain syndrome. 38
30963051 2019
20
Comparison of the Efficacies of Dry Needling and Botox Methods in the Treatment of Myofascial Pain Syndrome Affecting the Temporomandibular Joint. 38
30950954 2019
21
Myofascial component of cancer pain review. 38
31103113 2019
22
Association between naturally occurring spine osteoarthritis in geriatric rats and neurogenic inflammation within neurosegmentally linked skeletal muscle. 38
30615897 2019
23
Efficacy of Topical Vibratory Stimulation for Reducing Pain During Trigger Point Injection to the Gastrocnemius: a Randomized Controlled Trial. 38
30926293 2019
24
Kinesio taping versus dry needling in the treatment of myofascial pain of the upper trapezius muscle: A randomized, single blind (evaluator), prospective study. 38
30883331 2019
25
Fibromyalgia and myofascial pain syndrome: Two sides of the same coin? A scoping review to determine the lexicon of the current diagnostic criteria. 38
30350334 2019
26
Comparison of Upper Trapezius and Infraspinatus Myofascial Trigger Point Therapy by Dry Needling in Overhead Athletes With Unilateral Shoulder Impingement Syndrome. 38
29364040 2019
27
Intra-articular botulinum toxin injection in complex regional pain syndrome: Case report and review of the literature. 38
30660558 2019
28
Change in muscle hardness after trigger point injection and physiotherapy for myofascial pain syndrome. 38
30568046 2019
29
Association between child maltreatment and central sensitivity syndromes: a systematic review protocol. 38
30782933 2019
30
Effectiveness of active soft tissue release and trigger point block for the diagnosis and treatment of low back and leg pain of predominantly gluteus medius origin: a report of 115 cases. 38
30858653 2019
31
Comparison of intravenous NSAIDs and trigger point injection for low back pain in ED: A prospective randomized study. 38
30660342 2019
32
Dry needling versus friction massage to treat tension type headache: A randomized clinical trial. 38
30691768 2019
33
Experimental myofascial trigger point creation in rodents. 38
30307819 2019
34
Clinical features and myofascial pain syndrome in older adults with knee osteoarthritis by sex and age distribution: A cross-sectional study. 38
30528723 2019
35
The Effectiveness of Dry Needling and Exercise Therapy in Patients with Dizziness Caused By Cervical Myofascial Pain Syndrome; Prospective Randomized Clinical Study. 38
29718418 2019
36
Local Anesthetic Injections for the Short-Term Treatment of Head and Neck Myofascial Pain Syndrome: A Systematic Review with Meta-Analysis. 38
30893405 2019
37
Trigger point dry needling for the treatment of myofascial pain syndrome: current perspectives within a pain neuroscience paradigm. 38
31354339 2019
38
Does kinesiotaping increase the efficacy of lidocaine injection in myofascial pain syndrome treatment? A randomized controlled study. 38
30507559 2019
39
The myofascial component of the pain in the painful shoulder of the hemiplegic patient. 38
31038564 2019
40
Immediate effects of self-myofascial release on latent trigger point sensitivity: a randomized, placebo-controlled trial. 38
30765920 2018
41
Methodological Issues on the Accuracy and Precision of Clinical Examination in the Diagnosis of Myofascial Pain Syndrome. 38
29788387 2018
42
Reply to "Clinical Examination in the Diagnosis of Myofascial Pain Syndrome; Methodological Issues on Validity and Reliability". 38
29788501 2018
43
Effectiveness of Ultrasound Therapy on Myofascial Pain Syndrome of the Upper Trapezius: Randomized, Single-Blind, Placebo-Controlled Study. 38
30874250 2018
44
Myofascial Pain. 38
30522139 2018
45
Effect of aerobic exercise in the treatment of myofascial pain: a systematic review. 38
30656147 2018
46
Pathophysiology and Management of Abdominal Myofascial Pain Syndrome (AMPS): A Three-Year Prospective Audit of a Management Pathway in 120 Patients. 38
29444277 2018
47
Comparative study of shockwave therapy and low-level laser therapy effects in patients with myofascial pain syndrome of the trapezius. 38
30171341 2018
48
Does improvement towards a normal cervical sagittal configuration aid in the management of cervical myofascial pain syndrome: a 1- year randomized controlled trial. 38
30419868 2018
49
Anatomical variants of dorsal scapular nerve in relation to the middle scalene muscle in Japanese population. 38
30461656 2018
50
Myotonometry as a measure to detect myofascial trigger points: an inter-rater reliability study. 38
30475742 2018

Variations for Myofascial Pain Syndrome

Expression for Myofascial Pain Syndrome

Search GEO for disease gene expression data for Myofascial Pain Syndrome.

Pathways for Myofascial Pain Syndrome

GO Terms for Myofascial Pain Syndrome

Biological processes related to Myofascial Pain Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuropeptide signaling pathway GO:0007218 8.96 TAC1 POMC
2 regulation of blood pressure GO:0008217 8.62 TAC1 POMC

Molecular functions related to Myofascial Pain Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 signaling receptor binding GO:0005102 8.62 POMC PDGFRB

Sources for Myofascial Pain Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....